COMPENDIUM ON FUNCTIONAL MEDICINE - Flipbook - Page 716
[120] Hemmer B, Kerschensteiner M, Korn T. Role of the innate and
adaptive immune responses in the course of multiple sclerosis.
Lancet Neurol. 2015;14(4):406-419.
[121] Weetman AP. Autoimmune thyroid disease: propagation
and progression. Eur J Endocrinol. 2003;148(1):1-9.
[122] Pyzik A, Grywalska E, Matyjaszek-Matuszek B, Roliński J.
Immune Disorders in Hashimoto's Thyroiditis: What Do We Know So
Far? J Immunol Res. 2015;2015:979167.
[123] Virgin HW, Wherry EJ, Ahmed R. Redefining chronic viral
infection. Cell. 2009;138(1):30-50.
[124] Ewald PW. Evolution of infectious disease. Oxford University
Press; 1994.
[125] Tangye SG, Palendira U, Edwards ES. Human immunity
against EBV-lessons from the clinic. J Exp Med. 2017;214(2):269-283.
[126] Chijioke O, Müller A, Feederle R, et al. Human natural killer
cells prevent infectious mononucleosis features by targeting lytic
Epstein-Barr virus infection. Cell Rep. 2013;5(6):1489-1498.
[127] Klenerman P, Oxenius A. T cell responses to cytomegalovirus.
Nat Rev Immunol. 2016;16(6):367-377.
[128] Sylwester AW, Mitchell BL, Edgar JB, et al. Broadly targeted
human cytomegalovirus-specific CD4+ and CD8+ T cells dominate
the memory compartments of exposed subjects. J Exp Med.
2005;202(5):673-685.
[129] Steere AC, Strle F, Wormser GP, et al. Lyme borreliosis. Nat
Rev Dis Primers. 2016;2:16090.
[130] Marques A. Chronic Lyme disease: a review. Infect Dis Clin
North Am. 2008;22(2):341-360, vii-viii.
[131] Klenerman P, Hill A. T cells and viral persistence: lessons from
diverse infections. Nat Immunol. 2005;6(9):873-879.
716
